The relationship between interferon signaling and TP53 has been explored in the context of cancer75,76 and models of Down syndrome and Alzheimer’s disease, where blocking interferon signaling has been shown to limit senescence77. Here, TP53 is linked to early-onset autosomal dominant Alzheimer disease.